Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Hemophilia A Gene Therapy: BioMarin In Lead, Sangamo ‘Prays’ For Superior Results
Long-Term Efficacy Doubts Linger For Valrox
Nov 22 2019
•
By
Andrew McConaghie
BioMarin and Sangamo were both presenting at the Jefferies conference in London
More from Gene Therapies
More from Advanced Therapies